SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria

2008282 citationsJournal Articlegold Open Access

Authors

Paul J. Feldblum · Triangle

Adesina Adeiga · Nigerian Institute of Medical Research

R A Bakare · University of Ibadan

Silver Wevill · Triangle

Anja Lendvay · Triangle

Fatimah Obadaki · Nigerian Institute of Medical Research

M. Onikepe Olayemi ·

Abstract

SAVVY did not reduce the incidence of HIV infection. Although the hazard ratio was higher in the SAVVY than the placebo group, we cannot conclude that there was a harmful treatment effect of SAVVY.

Topics & Keywords

Reproductive tract infections research Pelvic floor disorders treatments HIV/AIDS Research and Interventions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PLoS ONE

Volume 3, Issue 1, pp. e1474-e1474

DOI: 10.1371/journal.pone.0001474

Field-Weighted Citation Impact: 29.22